Chemotherapeutic-induced apoptosis: A phenotype for pharmacogenomics studies

Pharmacogenetics and Genomics

Volumn 21, Issue 8, 2011, Pages 476-488

  Wen, Yujia ^a   Gorsic, Lidija K ^a   Wheeler, Heather E ^a   Ziliak, Dana M ^a   Stephanie Huang, Rong ^a   Dolan, Mary Eileen ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

apoptosis; caspase 3 7; genome wide association study; lymphoblastoid cell lines; toxicity

Indexed keywords

CARBOPLATIN; CASPASE 3; CASPASE 7; CISPLATIN; CYTARABINE; FLOXURIDINE; PACLITAXEL; PEMETREXED;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; PHARMACOGENOMICS; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79960837042     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3283481967     Document Type: Article

References (53)

1. Welsh M, Mangravite L, Medina MW, Tantisira K, Zhang W, Huang RS, et al. Pharmacogenomic discovery using cell-based models. Pharmacol Rev 2009; 61:413-429.
2. Dolan ME, Newbold KG, Nagasubramanian R,Wu X, Ratain MJ, Cook EH Jr, et al. Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity. Cancer Res 2004; 64:4353-4356. (Pubitemid 38802443)
3. Shukla SJ, Duan S, Badner JA,Wu X, Dolan ME. Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis. Pharmacogenet Genomics 2008; 18:253-262. (Pubitemid 351323240)
4. Watters JW, Kraja A, Meucci MA, Province MA, McLeod HL. Genome-wide discovery of loci influencing chemotherapy cytotoxicity. Proc Natl Acad Sci USA 2004; 101:11809-11814. (Pubitemid 39095376)
5. Bleibel WK, Duan S, Huang RS, Kistner EO, Shukla SJ,Wu X, et al. Identification of genomic regions contributing to etoposide-induced cytotoxicity. Hum Genet 2009; 125:173-180.
6. Duan S, Bleibel WK, Huang RS, Shukla SJ,Wu X, Badner JA, et al. Mapping genes that contribute to daunorubicin-induced cytotoxicity. Cancer Res 2007; 67:5425-5433. (Pubitemid 46997283)
7. Shukla SJ, Duan S, Wu X, Badner JA, Kasza K, Dolan ME. Whole-genome approach implicates CD44 in cellular resistance to carboplatin. Hum Genomics 2009; 3:128-142.
8. Ingle JN, Schaid DJ, Goss PE, Liu M, Mushiroda T, Chapman JA, et al. Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors. J Clin Oncol 2010; 28:4674-4682.
9. Chen SH, Yang W, Fan Y, Stocco G, Crews KR, Yang JJ, et al. A genomewide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity. Leukemia 2011; 25:66-74.
10. Huang RS, Duan S, Shukla SJ, Kistner EO, Clark TA, Chen TX, et al. Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach. Am J Hum Genet 2007; 81:427-437. (Pubitemid 47330203)
11. Ziliak DM, O'Donnell PH, Im HK, Gamazon ER, Chen P, Delaney SM, et al. Germline polymorphism discovered via a cell-based genome-wide approach predicts platinum response in head and neck cancers. Transl Res 2011; 157:265-272.
12. Huang RS, Duan S, Bleibel WK, Kistner EO, Zhang W, Clark TA, et al. A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. Proc Natl Acad Sci USA 2007; 104:9758-9763. (Pubitemid 47175340)
13. Hartford CM, Duan S, Delaney SM, Mi S, Kistner EO, Lamba JK, et al. Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity. Blood 2009; 113:2145-2153.
14. Niu N, Qin Y, Fridley BL, Hou J, Kalari KR, Zhu M, et al. Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines. Genome Res 2010; 20:1482-1492.
15. Ricci MS, Zong WX. Chemotherapeutic approaches for targeting cell death pathways. Oncologist 2006; 11:342-357.
16. Brown JM, Attardi LD. The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 2005; 5:231-237. (Pubitemid 40314954)
17. Iacobini M, Menichelli A, Palumbo G, Multari G, Werner B, Del Principe D. Involvement of oxygen radicals in cytarabine-induced apoptosis in human polymorphonuclear cells. Biochem Pharmacol 2001; 61:1033-1040. (Pubitemid 32247392)
18. Mielgo A, Torres VA, Clair K, Barbero S, Stupack DG. Paclitaxel promotes a caspase 8-mediated apoptosis through death effector domain association with microtubules. Oncogene 2009; 28:3551-3562.
19. Bischof M, Abdollahi A, Gong P, Stoffregen C, Lipson KE, Debus JU, et al. Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells. Int J Radiat Oncol Biol Phys 2004; 60:1220-1232. (Pubitemid 39440809)
20. Hsieh CH, Liu CY, Shueng PW, Chong NS, Chen CJ, Chen MJ, et al. Comparison of coplanar and noncoplanar intensity-modulated radiation therapy and helical tomotherapy for hepatocellular carcinoma. Radiat Oncol 2010; 5:40.
21. Kaushal GP, Kaushal V, Hong X, Shah SV. Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney Int 2001; 60:1726-1736. (Pubitemid 32999977)
22. Schmitz A, Bayer J, Dechamps N, Goldin L, Thomas G. Heritability of susceptibility to ionizing radiation-induced apoptosis of human lymphocyte subpopulations. Int J Radiat Oncol Biol Phys 2007; 68:1169-1177. (Pubitemid 47053954)
23. Camplejohn RS, Hodgson S, Carter N, Kato BS, Spector TD. Heritability of DNA-damage-induced apoptosis and its relationship with age in lymphocytes from female twins. Br J Cancer 2006; 95:520-524. (Pubitemid 44232562)
24. Stark AL, ZhangW, Mi S, Duan S, O'Donnell PH, Huang RS, et al. Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines. Pharmacogenomics J 2010; 10:505-512.
25. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281:1312-1316. (Pubitemid 28406817)
26. Abecasis GR, Cardon LR, Cookson WO. A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000; 66:279-292. (Pubitemid 30481489)
27. Gamazon ER, Huang RS, Cox NJ, Dolan ME. Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci. Proc Natl Acad Sci USA 2010; 107:9287-9292.
28. Gamazon ER, Zhang W, Konkashbaev A, Duan S, Kistner EO, Nicolae DL, et al. SCAN: SNP and copy number annotation. Bioinformatics 2010; 26:259-262.
29. Ramirez JM, Ocio EM, San Miguel JF, Pandiella A. Pemetrexed acts as an antimyeloma agent by provoking cell cycle blockade and apoptosis. Leukemia 2007; 21:797-804. (Pubitemid 46444565)
30. Kim GD, Rhee GS, Chung HM, Chee KM, Kim GJ. Cytotoxicity of 5-fluorouracil: effect on endothelial differentiation via cell cycle inhibition in mouse embryonic stem cells. Toxicol In Vitro 2009; 23:719-727.
31. Di Felice V, Lauricella M, Giuliano M, Emanuele S, Vento R, Tesoriere G. The apoptotic effects of cisplatin and carboplatin in retinoblastoma Y79 cells. Int J Oncol 1998; 13:225-232. (Pubitemid 28329208)
32. Watanabe KC, Jinnouchi K, Hess A, Michel O, Baba S, Yagi T. Carboplatin induces less apoptosis in the cochlea of guinea pigs than cisplatin. Chemotherapy 2002; 48:82-87. (Pubitemid 34507600)
33. Knox RJ, Friedlos F, Lydall DA, Roberts JJ. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA. Cancer Res 1986; 46:1972-1979. (Pubitemid 16080411)
34. Matoskova B, Wong WT, Salcini AE, Pelicci PG, Di Fiore PP. Constitutive phosphorylation of eps8 in tumor cell lines: relevance to malignant transformation. Mol Cell Biol 1995; 15:3805-3812.
35. Chen YJ, Shen MR, Chen YJ, Maa MC, Leu TH. Eps8 decreases chemosensitivity and affects survival of cervical cancer patients. Mol Cancer Ther 2008; 7:1376-1385.
36. Schuuring E. The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes-a review. Gene 1995; 159:83-96.
37. Al Zaid Siddiquee K, Turkson J. STAT3 as a target for inducing apoptosis in solid and hematological tumors. Cell Res 2008; 18:254-267. (Pubitemid 351206162)
38. Mehta DS,Wurster AL,Whitters MJ, Young DA, Collins M, Grusby MJ. IL-21 induces the apoptosis of resting and activated primary B cells. J Immunol 2003; 170:4111-4118. (Pubitemid 36428174)
39. El Hour M, Moncada-Pazos A, Blacher S, Masset A, Cal S, Berndt S, et al. Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis. Oncogene 2010; 29:3025-3032.
40. Moncada-Pazos A, Obaya AJ, Fraga MF, Viloria CG, Capella G, Gausachs M, et al. The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer. J Cell Sci 2009; 122:2906-2913.
41. Kinsella AR, Smith D. Tumor resistance to antimetabolites. Gen Pharmacol 1998; 30:623-626. (Pubitemid 28167762)
42. Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 2007; 33:9-23. (Pubitemid 46137553)
43. Jordan MA,Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004; 4:253-265. (Pubitemid 38525281)
44. Prakasha Gowda AS, Polizzi JM, Eckert KA, Spratt TE. Incorporation of gemcitabine and cytarabine into DNA by DNA polymerase beta and ligase III/XRCC1. Biochemistry 2010; 49:4833-4840.
45. Richardson KA, Vega TP, Richardson FC, Moore CL, Rohloff JC, Tomkinson B, et al. Polymerization of the triphosphates of AraC, 20,20-difluorodeoxycytidine (dFdC) and OSI-7836 (T-araC) by human DNA polymerase alpha and DNA primase. Biochem Pharmacol 2004; 68:2337-2346. (Pubitemid 39535106)
46. Xu JH, Huang HZ, Pan CB, Zhang B, Zhang LT. Role of survivin gene on the apoptosis of Tca8113 cells induced by cisplatin. Hua Xi Kou Qiang Yi Xue Za Zhi 2007; 25:173-176.
47. Cande C, Cohen I, Daugas E, Ravagnan L, Larochette N, Zamzami N, et al. Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria. Biochimie 2002; 84:215-222.
48. Zhao T, Zhang H, Guo Y, Zhang Q, Hua G, Lu H, et al. Granzyme K cleaves the nucleosome assembly protein SET to induce single-stranded DNA nicks of target cells. Cell Death Differ 2007; 14:489-499.
49. Broker LE, Huisman C, Span SW, Rodriguez JA, Kruyt FA, Giaccone G. Cathepsin B mediates caspase-independent cell death induced by microtubule stabilizing agents in non-small cell lung cancer cells. Cancer Res 2004; 64:27-30. (Pubitemid 38114077)
50. Fulda S. Tumor resistance to apoptosis. Int J Cancer 2009; 124:511-515.
51. Flick MB, O'Malley D, Rutherford T, Rodov S, Kamsteeg M, Hao XY, et al. Apoptosis-based evaluation of chemosensitivity in ovarian cancer patients. J Soc Gynecol Investig 2004; 11:252-259. (Pubitemid 38561371)
52. Ballard KS, Homesley HD, Hodson C, Presant CA, Rutledge J, Hallquist A, et al. Endometrial carcinoma in vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic apoptosis assay: implications for endometrial cancer treatment. J Gynecol Oncol 2010; 21:45-49.
53. Adourian A, Jennings E, Balasubramanian R, Hines WM, Damian D, Plasterer TN, et al. Correlation network analysis for data integration and biomarker selection. Mol Biosyst 2008; 4:249-259. (Pubitemid 351272685)